FutureChem Co (XKRX:220100) Total Liabilities : ₩19,904 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is FutureChem Co Total Liabilities?

FutureChem Co's Total Liabilities for the quarter that ended in Dec. 2024 was ₩19,904 Mil.

FutureChem Co's quarterly Total Liabilities increased from Jun. 2024 (₩8,373.24 Mil) to Sep. 2024 (₩22,774.35 Mil) but then declined from Sep. 2024 (₩22,774.35 Mil) to Dec. 2024 (₩19,904.48 Mil).

FutureChem Co's annual Total Liabilities declined from Dec. 2022 (₩18,433.02 Mil) to Dec. 2023 (₩8,918.81 Mil) but then increased from Dec. 2023 (₩8,918.81 Mil) to Dec. 2024 (₩19,904.48 Mil).

FutureChem Co Total Liabilities Historical Data

The historical data trend for FutureChem Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FutureChem Co Total Liabilities Chart

FutureChem Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

38,841.49

24,221.47

18,433.02

8,918.81

19,904.48

FutureChem Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															8,918.81	9,011.97	8,373.24	22,774.35	19,904.48

FutureChem Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

FutureChem Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	15775.845	+	(1807.885	+	1962.563
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	358.184)
	=	19,904

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	74421.441	-	54516.964
	=	19,904

FutureChem Co's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	15775.845	+	(1807.885	+	1962.563
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	358.184)
	=	19,904

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	74421.441	-	54516.964
	=	19,904

FutureChem Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of FutureChem Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

FutureChem Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » FutureChem Co Ltd (XKRX:220100) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

2Floor, 21, Yeonmujang 3-gil, Seongdong-gu, Seoul, KOR, 04782

Website

http://www.futurechem.co.kr

FutureChem Co Ltd is a radiopharmaceuticals company engaged in manufacturing related precursors chemicals, automatic synthesizer, and synthesis reagents and develops & commercializes new traces with research and development. It offers radiopharmaceuticals for diagnosing cancers, and Alzheimer's diseases; and automation modules and disposable goods, such as disposable cassettes, reagent kits, and radio-caps. It also provides peptide-based radiopharmaceuticals for radio-metal chelation and click reaction; linkers for bio-conjugation using copper-free/mediated click reaction. In addition, the company is involved in the research and development of radioisotope labeling technology; and automation devices. Further, it offers amino acids and reagents for peptides; and ionic liquids.

FutureChem Co Headlines

No Headlines